BioIVT

Biotechnology Research • Hicksville, New York, United States • 201-500 Employees

Company overview

Headquarters	Post Office Box 770, Hicksville, NY 11802, US
Phone number	+15164831196
Website	bioivt.com
NAICS	541714
SIC	873
Keywords	High Level Of Customer Service, Customized For Every Individual Order, Products Delivered In A Timely Matter, Ready For Use, Unconditional Product Guarantee, Adme Research Services To Match Program Goals
Founded	1981
Employees	201-500
Socials

Key Contacts at BioIVT

Laurie Clotilde

Global Strategic Account Director

Karen Spiller Tiano

Internal & Executive Communication Director

Bryan Mcdowl

Senior Director Human Resources

Judith Dunn

Member Board Of Directors

Lauren Houghtalin

Director, Technical Sales North America Disease State & Cell And Gene Therapy

Jehane Walsh

Senior Director, Treasury & Corporate Tax

Calvin Cortes

Senior Director Commercial Excellence

Cathie G. Miller

Senior Director Of Product Management

Kevin Mertz

Senior Director, Regional Business Development, East Coast

Christopher Reed

Director, Cell And Gene Therapy, Technical Sales

BioIVT Email Formats

BioIVT uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@bioivt.com), used 52.5% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@bioivt.com	52.5%
{first initial}{last name}	jdoe@bioivt.com	43.5%
{last name}{last name}	doedoe@bioivt.com	3.4%

About BioIVT

BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. We specialize in control and disease state samples including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. Our Research Services team works collaboratively with clients to provide in vitro hepatic modeling solutions. And as the world’s premier supplier of ADME-Tox model systems, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and the effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.

BioIVT revenue & valuation

Annual revenue	$45,000,000
Revenue per employee	$94,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$144,000,000
Total funding	$45,000,000

Employees by Management Level

Total employees: 201-500

Seniority

Employees

Entry

Manager

Director

Employees by Department

BioIVT has 224 employees across 16 departments.

Departments

Number of employees

Funding Data

Explore BioIVT's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2013-08-16	12	$45,000,000

Funding Insights

$45,000,000

Total funding amount

$45,000,000

Most recent funding amount

Number of funding rounds

BioIVT Tech Stack

Discover the technologies and tools that power BioIVT's digital infrastructure, from frameworks to analytics platforms.

Redux

JavaScript frameworks

Contentful

CMS

Cookie Control

Cookie compliance

Goober

JavaScript libraries

Hotjar

Analytics

Microsoft 365

Algolia

Search engines

Google Ads

Advertising

HubSpot Analytics

Analytics

Apple iCloud Mail

Webmail

Hammer.js

JavaScript libraries

Google AdSense

Advertising

Frequently asked questions

BioIVT is located in Hicksville, New York, US.

You can reach BioIVT at +15164831196.

BioIVT was founded in 1981, making it 45 years old. The company has established itself as a significant player in its industry over this time.

BioIVT has approximately 201-500 employees. The company continues to grow its workforce to support its business operations and expansion.

BioIVT has raised a total of $45,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.